Financials and Corporate
Innate Pharma obtains ISO9001:2000 certification for its research and development activities in the field of immunotherapy
This certification marks a new milestone in the maturation of the company, obtained at a time when Innate Pharma is significantly building up its team, enlarging its portfolio of compounds and working...
Innate Pharma welcomes Dr. Squiban as Chief Medical Officer
Dr. Squiban, 53, joined Innate Pharma after eight years at Transgene (1997-2005), a French company dedicated to the discovery and development of therapeutic vaccines and gene therapy products, as...